About

Lipidomics Standards Initiative (LSI) was initiated 2018 by Kim Ekroos and Gerhard Liebisch. Both are currently coordinating efforts to develop guidelines for Lipidomics.

Current members

  • Robert Ahrends, Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Austria
  • Masanori Arita, RIKEN Center for Sustainable Resource Science, Yokohama, Japan, National Institute of Genetics, Mishima, Japan
  • Takeshi Bamba, Division of Metabolomics, Medical Institute of Bioregulation, Kyushu University, Japan
  • Steffany Bennett, India Taylor Lipidomics Research Platform, University of Ottawa, Ottawa, Canada
  • Justine Bertand-Michel, MetaToul-Lipidomic MetaboHUB Core Facility, Inserm, Toulouse, France
  • Stephen Blanksby, Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology, Brisbane, Australia
  • John Bowden, Chemical Sciences Division, Hollings Marine Laboratory, National Institute of Standards and Technology, Charleston, USA
  • Ralph Burkhardt, Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany
  • Christer Ejsing, Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences, University of Southern Denmark, Odense, Denmark
  • Kim Ekroos, Lipidomics Consulting Ltd., Esbo, Finland
  • Shane Ellis, M4I Institute, The Maastricht Multimodal Molecular Imaging Institute, Maastricht University, The Netherlands
  • Maria Fedorova, Institute of Bioanalytical Chemistry, Faculty of Chemistry and Mineralogy, University of Leipzig, Germany
  • Bill Griffiths, Swansea University Medical School, Swansea, UK
  • Xianlin Han, Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute, Orlando, USA
  • Nils Hoffmann, Institute for Bio- and Geosciences (IBG-5),Forschungszentrum Jülich GmbH, Jülich, Germany
  • Michal Holčapek, Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Czech Republic
  • Harald Köfeler, Core Facility for Mass Spectrometry and Lipidomics, Medical University of Graz, Austria
  • Dominik Kopczynski, Department of Analytical Chemistry, Facultyof Chemistry, University of Vienna, Austria
  • Jeff McDonald, Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, USA
  • Gerhard Liebisch, Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany
  • Arita Makoto, Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences (IMS), Tsurumi, Yokohama, Japan
  • Todd Mitchell, School of Medicine, Illawarra Health and Medical Research Institute, University of Wollongong, Australia
  • Valerie O’Donnell, Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University, UK
  • Gavin Reid, Department of Biochemistry and Molecular Biology, University of Melbourne, Australia
  • Dominik Schwudke, Division of Bioanalytical Chemistry, Research Center Borstel, Germany
  • Andrej Shevchenko, MPI of Molecular Cell Biology and Genetics , Dresden, Germany
  • Michael Wakelam, Babraham Institute, Cambridge, UK
  • Markus Wenk, Singapore Lipidomics Incubator (SLING), Department of Biochemistry, YLL School of Medicine, National University of Singapore
  • Dayanjan Wijesinghe, School of Pharmacy, Virginia Commonwealth University, Richmond, USA